Citigroup’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-26,026
| Closed | -$104K | – | 7938 |
|
|
2019
Q4 | $104K | Sell |
26,026
-104,125
| -80% | -$489K | ﹤0.01% | 5745 |
|
|
2019
Q3 | $638K | Sell |
130,151
-5,367
| -4% | -$30K | ﹤0.01% | 4107 |
|
|
2019
Q2 | $825K | Buy |
135,518
+6,998
| +5% | +$37.2K | ﹤0.01% | 3874 |
|
|
2019
Q1 | $747K | Buy |
128,520
+38,418
| +43% | +$397K | ﹤0.01% | 3732 |
|
|
2018
Q4 | $1.21M | Buy |
90,102
+14,709
| +20% | +$248K | ﹤0.01% | 3203 |
|
|
2018
Q3 | $1.46M | Buy |
75,393
+40,008
| +113% | +$852K | ﹤0.01% | 3069 |
|
|
2018
Q2 | $904K | Buy |
35,385
+13,742
| +63% | +$320K | ﹤0.01% | 3468 |
|
|
2018
Q1 | $436K | Sell |
21,643
-50,525
| -70% | -$1.18M | ﹤0.01% | 4134 |
|
|
2017
Q4 | $1.45M | Sell |
72,168
-52,258
| -42% | -$1.03M | ﹤0.01% | 2964 |
|
|
2017
Q3 | $2.58M | Sell |
124,426
-77,461
| -38% | -$1.31M | ﹤0.01% | 2395 |
|
|
2017
Q2 | $2.99M | Buy |
201,887
+98,914
| +96% | +$1.65M | ﹤0.01% | 2164 |
|
|
2017
Q1 | $1.64M | Buy |
102,973
+15,930
| +18% | +$230K | ﹤0.01% | 2670 |
|
|
2016
Q4 | $1.1M | Buy |
87,043
+86,409
| +13,629% | +$1.61M | ﹤0.01% | 3586 |
|
|
2016
Q3 | $18K | Sell |
634
-442
| -41% | -$14.8K | ﹤0.01% | 6267 |
|
|
2016
Q2 | $38K | Sell |
1,076
-25,317
| -96% | -$796K | ﹤0.01% | 5751 |
|
|
2016
Q1 | $723K | Buy |
26,393
+25,393
| +2,539% | +$748K | ﹤0.01% | 3720 |
|
|
2015
Q4 | $34K | Buy |
1,000
+365
| +57% | +$11.4K | ﹤0.01% | 6201 |
|
|
2015
Q3 | $18K | Sell |
635
-35
| -5% | -$1.5K | ﹤0.01% | 6116 |
|
|
2015
Q2 | $30K | Sell |
670
-524
| -44% | -$19.7K | ﹤0.01% | 5869 |
|
|
2015
Q1 | $41K | Sell |
1,194
-1,791
| -60% | -$48.7K | ﹤0.01% | 5656 |
|
|
2014
Q4 | $82K | Buy |
+2,985
| New | +$72.4K | ﹤0.01% | 5383 |
|
Other funds holding DPLO
Citigroup's DPLO Position: Q1 2020 in Review
Citigroup sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 26,026 shares — an estimated $104K sold.
Citigroup first reported a position in DPLO in Q4 2014 and held it in 21 quarters. The position peaked at $2.99M in Q2 2017. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- Citigroup reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- Citigroup sold 26,026 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $104K.
- Citigroup first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 21 quarters.
- Citigroup's DIPLOMAT PHARMACY, INC. position peaked at $2.99M in Q2 2017.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on Citigroup's 13F filing for Q1 2020, filed 12 May 2020.